Dual time point [18F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues

Archive ouverte

Lovinfosse, Pierre | Rousseau, Caroline | Pierga, Jean-Yves | Bouchet, Francis | Cochet, Alexandre | Alberini, Jean-Louis | Girault, Sylvie | Vera, Pierre | Olivier, Pierre | Uwer, Lionel | Cachin, Florent | Scarwell, Benoit | Lemonnier, Jérome | Fourme, Emmanuelle | Mesleard, Christel | Martin, Anne-Laure | Lacœuille, Franck | Couturier, Olivier-François

Edité par CCSD ; SpringerOpen -

International audience. For differentiating tumor from inflammation and normal tissues, fluorodeoxyglucose ([18F]FDG) dual time point PET could be helpful. Albeit [18F]FLT is more specific for tumors than [18F]FDG; we explored the role of dual time point [18F]FLT-PET for discriminating benign from malignant tissues.

Consulter en ligne

Suggestions

Du même auteur

Calibration test of PET scanners in a multi-centre clinical trial on breast cancer therapy monitoring using 18F-FLT.

Archive ouverte | Bouchet, Francis | CCSD

International audience. UNLABELLED: A multi-centre trial using PET requires the analysis of images acquired on different systems We designed a multi-centre trial to estimate the value of 18F-FLT-PET to predict respo...

Dual time point 3'-fluorine-18-3'-deoxy-L-thymidine (FLT) positron emission tomography (PET) for differentiate normal or tumor proliferating tissues vs non-proliferating normal tissues

Archive ouverte | Lovinfosse, P. | CCSD

International audience

Apport de la TEP-FDG dans le staging initial des cancers du sein localement avancés traités par chimiothérapie néo-adjuvante

Archive ouverte | Fosse, Pacôme | CCSD

International audience. Axillary lymph node and distant metastases are unfavourable prognostic factors in breast cancer. The aim of our study was to evaluate the performance of PET-FDG in the staging of locally adva...

Chargement des enrichissements...